These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18361906)

  • 1. [The high-sensitivity C-reactive protein level one month after bare-metal coronary stenting may predict late adverse events].
    Fournier JA; Delgado-Pecellín C; Cayuela A; Cabezón S; Mendoza MD
    Rev Esp Cardiol; 2008 Mar; 61(3):313-6. PubMed ID: 18361906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
    Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high-sensitivity C-reactive protein].
    Lozano T; Ena J; Almenar V; Graells M; Molina J; Antorrena I; de la Guía F
    Rev Esp Cardiol; 2007 Aug; 60(8):817-24. PubMed ID: 17688850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina.
    Goldberg A; Gruberg L; Roguin A; Petcherski S; Rimer D; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2006 Jun; 151(6):1265-70. PubMed ID: 16781234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
    Sierros V; Fleming R; Cascioli M; Brady T
    Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
    Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
    Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
    Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.
    Hogh AL; Joensen J; Lindholt JS; Jacobsen MR; Ostergaard L
    Vasc Endovascular Surg; 2008; 42(4):341-7. PubMed ID: 18458051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-reactive protein, leukocyte count and D-dimer monitoring after orthopedic surgery: early diagnosis of infectious or thromboembolic complications. Part one: C-reactive protein and leukocyte count as an aid in diagnosing postoperative infection].
    Codine P; Barbotte E; Denis-Laroque F; Lansac H; Dupetit T; Pradies F; Ricart B; Herisson C
    Ann Readapt Med Phys; 2005 Nov; 48(8):590-7. PubMed ID: 15961180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
    Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.